Skip to content

Advertisement

  • Poster presentation
  • Open Access

HIV infected pregnant women monitored in the Adults 3 Department of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş” – risk of mother to child transmission

  • 1, 2Email author,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1, 2,
  • 1,
  • 1, 2,
  • 1, 2,
  • 1, 2,
  • 1,
  • 1, 2,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1, 2
BMC Infectious Diseases201313 (Suppl 1) :P26

https://doi.org/10.1186/1471-2334-13-S1-P26

  • Published:

Keywords

  • Pregnant Woman
  • Caesarean Delivery
  • Viramune
  • Transmission Risk
  • Child Infection

Background

It was estimated that at the end of 2010 more than 34 million people are infected with HIV worldwide and 50% of them are women. After 1989 in Romania, mother-to-child transmission of HIV remains the primary way of child infection with HIV. We analyzed mother to child transmission risk factors between 2005 and 2013.

Methods

We analyzed 18 mother-infant pairs in order to establish the risk factors for HIV transmission. We performed a retrospective study of the HIV infected women monitored in the Adults 3 Department of the National Institute for Infectious Diseases “Prof. Dr. Matei Balş”.

Results

Only 8 of the pregnant women discovered the HIV infection before childbirth and received antiviral prophylaxis: 6 with combivir and lopinavir/r, 1 with combivir and atazanavir/r and 1 with combivir and viramune. All of these patients had caesarean delivery and formula feeding for the child. All new-born were HIV negative. 10 women were diagnosed with HIV infection after the delivery: 9 had a vaginal delivery and one caesarean delivery. None of the women took chemoprophylaxis and all patients breastfed the children. 2 children were HIV positive. Both HIV positive children were born from mothers with high viral loads and low CD4 counts.

Conclusion

All pregnant women must be HIV-tested before delivery in order to reduce the risk of mother-to-child transmission of HIV.

Authors’ Affiliations

(1)
National Institute for Infectious Diseases “Prof. Dr. Matei Balş”, Bucharest, Romania
(2)
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Copyright

Advertisement